Operator of a health advisory platform intended to help every person to achieve their own definition of optimal health.
Operator of a health advisory platform intended to help every person to achieve their own definition of optimal health.
Clinics/Outpatient Services📍 San Francisco, CAFounded 2017
Current Valuation
$600M
as of 2023-Q1
PRIVATE
QL Price
$306.21M
-49% vs last round
QuantLogix's current estimate for Tia, published 2026-09-27 — below the last disclosed round of $600M (2023-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$600M
2023-Q1
weight 0.09
Secondary market print
$261M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Tia since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Tia, 2026-09-27 (5c3b00deabb5ba5e).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Tia going public?
No. Tia is private and has not filed to go public. There is no S-1 on file.
What is Tia's valuation in 2026?
Tia is valued at $600M as of 2023-Q1, set by its Series C1 ($100M, Mar 2023). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Tia filed an S-1?
No public S-1 is on file for Tia.
How much has Tia raised?
Tia has raised $157M in total, most recently a Series C1 of $100M in Mar 2023.
Is Tia publicly traded — can you buy Tia stock?
No. Tia is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Tia on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2017
HQ
San Francisco, CA
Employees
406
Total Raised
$157M
Last Round
Series C1 — $100M (Mar 2023)
IPO Status
private
Fundraising Status
Series C1 · $100M · 3y 6mo ago
privateTotal raised $157M
Secondary Market
Implied price / share
$5.95
Last round price / share
$13.67
vs last round
-56.5%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C1
$100M
Mar 2023
—
$600M
Talent Signal
Hiring trend
▼ Hiring downtrend
-17% vs 2026-08
Open roles
24
via greenhouse
Product-build share
50%
engineering, research, product, design
Trajectory
tightening
product-led hiring — 50% of open roles build product; the rest are go-to-market and G&A.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Lead Primary Care Physician, Women’s Health, Silver LakeMedical Assistant - Pasadena, CA - OnsiteMedical Assistant - Playa Vista - OnsiteMedical Assistant - Scottsdale, AZ - OnsiteMedical Assistant - Studio City, CA - OnsiteNurse Practitioner or Physician Assistant, Primary Care / Women’s Health
Counted from Tia's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
AppsFitnessHealth Care
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q1. Refreshed quarterly.